References
- Wetzler S, Katz MM. Problems with the differentiation of anxiety and depression. J Psychiatr Res 1989; 23: 1–12
- Alnaes R, Torgensen S. DSM-III personality disorders among patients with major depression, anxiety disorders, and mixed conditions. J Nerv Ment Dis 1990; 178: 693–8
- Liebowitz M R., Hollander E, Schneier F, et al. Anxiety and depression: discrete diagnostic entities?. J Clin Psychopharmacol 1990; 10: 61S–66S, suppl 3
- Katon W, Roy-Byme PP. Mixed anxiety and depression. J Abnorm Psychol 1991; 100: 337–45
- Clayton PJ. The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 1990; 51: 35–39, suppl
- Stein M B., Shea C A., Uhde TW. Social phobic symptoms in patients with panic disorder: practical and theoretical implications. Am J Psychiatry 1989; 146: 235–8
- Rudd M D., Dahm P F., Rajab MH. Diagnostic comorbidity in persons with suicidal ideation and behavior. Am J Psychiatry 1993; 150: 928–34
- Wittchen H-U, Essau C A., Krieg J-C. Anxiety disorders: similarities and differences of comorbidity in treated and untreated groups. Br J Psychiatry 1991; 159: 23–33, suppl
- Clayton PJ. Anxious depression: a reemerging subtype of depression. Anxious depression: assessment and treatment, G. Racagni, E. Smeraldi. Raven Press, New York 1987; 1–6
- Zajecka J M., Tracy K A., Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry 1997; 58: 291–7
- Fawcett J, Marcus RN., Anton G, et al. Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatry 1995; 56: 37–42, suppl 6
- Zajecka JM. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatients settings. J Clin Psychiatry 1996; 57: 10–14, suppl 2
- Ballenger JC. Pharmacotherapy of the panic disorders. J Clin Psychiatry 1986; 47: 27–32, suppl
- DeVeaugh-Geiss J, Landaw P, Katz R. Treatment of obsessive-compulsive disorder with clomipramine. Psychiatr Ann 1989; 19: 97–101
- Liebowitz M R., Campeas R, Levin A, et al. Pharmacotherapy of social phobia: a condition distinct from panic attacks. Psychosomatics 1987; 28: 305–8
- Liebowitz M R., Quitkin F M., Steward JW, et al. Phenelzine vs. imipramine in atypical depression. Arch Gen Psychiatry 1984; 41: 669–77
- Schneier F R., Liebowitz M R., Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990; 10: 119–21
- Primeau F, Fontaine R, Beauclair L. Valproic acid and panic disorder. Can J Psychiatry 1990; 35: 248–50
- Zajecka J, Fanelli J, Ross J, et al. Valproic acid in the treatment of panic disorder (Poster). New Clinical Drug Evaluation Unit meeting organised by the Division of Clinical and Treatment Research. National Institute of Mental Health, Marco Island, Fl 1994
- Barlow DH. Anxiety and its disorders. The nature and treatment of anxiety and panic, DH. Barlow. Guilford Press, New York 1988; 425–7
- Van der Kolk B A., Dreyfuss D, Michaels M. Fluoxetine in post-traumatic stress disorder. J Clin Psychiatry 1994; 55: 517–22
- Davidson J RT. Drug therapy of post-traumatic stress disorder. Br J Psychiatry 1992; 160: 309–14
- Goodman W K., McDougle C J., Price LH. Pharmacotherapy of obsessive compubive disorder. J Clin Psychiatry 1992; 53: 29–37, suppl
- Zetin M, Kramer MA. Obsessive-compulsive disorder. Hosp Community Psychiatry 1992; 43: 689–99